Maher Salamoon, Sr., MD

Consultant hematology/oncology
Al Bairouni University Cancer Center, Syria

maher Salamoon obtained his medical diploma from Damascus school of medicine in Syria in 1998 and a master degree in medical oncology and hematology in 2003. he performed a sub-specialty in lymphoma and bone marrow transplant from Curie institute, Lyon-sud and la Timone in France. a cancer biology and translational research from Curie institute in Paris and hospital clinic in Barcelona. he has more than 100 international publications and contributed more than 300 scientific papers in international meetings. he is a part of editorial board of several journals of medical oncology and hematology

Poster(s):

• LB04 - Factors predicting pulmonary infections in chronic lymphocytic leukemia (CLL) treated with targeted therapies with a history of lung diseases: factors are IGHV, TP53 (low and high burden) and COBBLL1

• LB08 - Secondary factors in chronic lymphocytic leukemia (CLL) such as COBBLL1 and response prediction in TP53 non-mutant cohort treated with single agent venetoclax or Obinutuzumab